NCT04694482View on ClinicalTrials.gov

The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Psychosis;SchizophrenicPersonality DisordersMood DisordersAnxiety DisordersPost Traumatic Stress Disorder
Interventions
OTHER

Psychometric scale administration

PTSD symptoms are assessed using a specific scale (IES-R) and compared between the two groups

Trial Locations (1)

20900

University of Milan Bicocca - Ospedale San Gerardo, Monza

All Listed Sponsors
collaborator

Azienda Ospedaliera San Gerardo di Monza

OTHER

lead

University of Milano Bicocca

OTHER

NCT04694482 - The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology | Biotech Hunter | Biotech Hunter